Therapeutic options in multiple sclerosis: five new things

Neurology. 2010 Nov 2;75(18 Suppl 1):S22-7. doi: 10.1212/WNL.0b013e3181fb3676.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Biomarkers / metabolism
  • Humans
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / metabolism
  • Multiple Sclerosis / therapy*
  • Natalizumab
  • Nerve Regeneration / drug effects
  • Nerve Regeneration / physiology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • Immunologic Factors
  • Natalizumab